59N

8-[(trans-4-aminocyclohexyl)methyl]-6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(ethylamino)pyrido[2,3-d]pyrimidin-7(8H)-one

Created:	2015-08-27
Last modified:	2016-09-21

Find Related PDB Entry
1 entries where 59N is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	66
Chiral Atom Count	0
Bond Count	70
Aromatic Bond Count	18

2D diagram of 59N

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	8-[(trans-4-aminocyclohexyl)methyl]-6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(ethylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
Systematic Name (OpenEye OEToolkits)	8-[(4-azanylcyclohexyl)methyl]-6-[2-chloranyl-4-(6-methylpyrazin-2-yl)phenyl]-2-(ethylamino)pyrido[2,3-d]pyrimidin-7-one
Formula	C₂₇ H₃₀ Cl N₇ O
Molecular Weight	504.026
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	N(c4nc3N(C(=O)C(c1ccc(cc1Cl)c2nc(cnc2)C)=Cc3cn4)CC5CCC(N)CC5)CC
SMILES	CACTVS	3.385	CCNc1ncc2C=C(C(=O)N(C[CH]3CC[CH](N)CC3)c2n1)c4ccc(cc4Cl)c5cncc(C)n5
SMILES	OpenEye OEToolkits	1.9.2	CCNc1ncc2c(n1)N(C(=O)C(=C2)c3ccc(cc3Cl)c4cncc(n4)C)CC5CCC(CC5)N
Canonical SMILES	CACTVS	3.385	CCNc1ncc2C=C(C(=O)N(C[C@H]3CC[C@H](N)CC3)c2n1)c4ccc(cc4Cl)c5cncc(C)n5
Canonical SMILES	OpenEye OEToolkits	1.9.2	CCNc1ncc2c(n1)N(C(=O)C(=C2)c3ccc(cc3Cl)c4cncc(n4)C)CC5CCC(CC5)N
InChI	InChI	1.03	InChI=1S/C27H30ClN7O/c1-3-31-27-32-13-19-10-22(21-9-6-18(11-23(21)28)24-14-30-12-16(2)33-24)26(36)35(25(19)34-27)15-17-4-7-20(29)8-5-17/h6,9-14,17,20H,3-5,7-8,15,29H2,1-2H3,(H,31,32,34)/t17-,20-
InChIKey	InChI	1.03	PJYRMGKJLXENCU-IRJFHVNHSA-N

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.